Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis Larson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neuroscience|July 13, 2019
Scopolamine and Medial Frontal Stimulus-Processing during Interval TimingQiang Zhang, Dennis Jung, Travis Larson, et al.
Neuroscience Letters|October 3, 2021
Cortical alpha-synuclein preformed fibrils do not affect interval timing in miceQiang Zhang, Hisham Abdelmotilib, Travis Larson, et al.
Behavioural Brain Research|June 19, 2022
Mice expressing P301S mutant human tau have deficits in interval timingTravis Larson, Vaibhav Khandelwal, Matthew A Weber, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Glycolysis-enhancing α1-adrenergic antagonists are neuroprotective in Alzheimer's diseaseQiang Zhang, Jordan Schultz, Jacob Simmering, et al.
Alzheimer'S Research & Therapy|July 10, 2026
Glycolysis-enhancing α<sub>1</sub>-adrenergic antagonists have therapeutic potential in Alzheimer's diseaseQiang Zhang, Jordan L Schultz, Jacob E Simmering, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neuroscience|July 13, 2019
Scopolamine and Medial Frontal Stimulus-Processing during Interval TimingQiang Zhang, Dennis Jung, Travis Larson, et al.
Neuroscience Letters|October 3, 2021
Cortical alpha-synuclein preformed fibrils do not affect interval timing in miceQiang Zhang, Hisham Abdelmotilib, Travis Larson, et al.
Behavioural Brain Research|June 19, 2022
Mice expressing P301S mutant human tau have deficits in interval timingTravis Larson, Vaibhav Khandelwal, Matthew A Weber, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Glycolysis-enhancing α1-adrenergic antagonists are neuroprotective in Alzheimer's diseaseQiang Zhang, Jordan Schultz, Jacob Simmering, et al.
Alzheimer'S Research & Therapy|July 10, 2026
Glycolysis-enhancing α<sub>1</sub>-adrenergic antagonists have therapeutic potential in Alzheimer's diseaseQiang Zhang, Jordan L Schultz, Jacob E Simmering, et al.
Pageof 1